Cardiology Online - International Academy of Cardiology
»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Discussion Groups
   Job Opportunities
   Contact Us





19th World Congress on Heart Disease



Mandeep S. Sidhu, M.D., Albany Medical College, Albany, NY, USA


The optimal strategy for the management of patients with stable ischemic heart disease (SIHD) has been a matter of considerable debate over the past two decades. During this time period, there have been notable technologic evolutions in catheter-based revascularization that include the advent of bare metal and drug-eluting stents, the genesis of more effective antiplatelet therapy, the continued refinement of stent delivery platforms, improving operator experience and quality improvement initiatives which have led to declining complication rates. As a result, the approach to the management of SIHD has shifted increasingly from an initial pharmacologic strategy to one that embraces an initial percutaneous coronary intervention (PCI) approach. However, such a management paradigm is not fully supported by robust outcomes data, which suggests the need for a critical reappraisal of contemporary clinical practice. In particular, clinical decision-making is now better informed because of the results of several important randomized control trials that have rigorously compared the hard clinical endpoints of death and myocardial infarction (MI) in patients with SIHD who have undergone PCI with contemporary, guideline-directed medical therapy combined with lifestyle intervention.



©1998-2015 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.